Platelet expression of stromal cell-derived factor-1 is associated with the degree of valvular aortic stenosis

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Wurster, Thomas ^a   Tegtmeyer, Roland ^a   Borst, Oliver ^a   Rath, Dominik ^a   Geisler, Tobias ^a   Gawaz, Meinrad ^a   Bigalke, Boris ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

STROMAL CELL DERIVED FACTOR 1;

ACUTE CORONARY SYNDROME; ADULT; AGED; AORTA VALVE STENOSIS; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; PROTEIN EXPRESSION; THROMBOCYTE; ECHOCARDIOGRAPHY; HEMODYNAMICS; METABOLISM; PATHOLOGY;

AORTIC VALVE STENOSIS; BLOOD PLATELETS; CHEMOKINE CXCL12; ECHOCARDIOGRAPHY; FLOW CYTOMETRY; HEMODYNAMICS; HUMANS;

EID: 84901350243     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097405     Document Type: Article

References (34)

1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, et al. (2006) Burden of valvular heart diseases: a population-based study. Lancet 368: 1005-1011. (Pubitemid 44353666)
2. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, et al. (1997) Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 29: 630-634. (Pubitemid 27116107)
3. Aronow WS, Ahn C, Shirani J, Kronzon I (1999) Comparison of frequency of new coronary events in older subjects with and without valvular aortic sclerosis. Am J Cardiol 83: 599-600, A598.
4. Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, et al. (2003) Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107: 1322-1328. (Pubitemid 36314418)
5. Kucia M, Reca R, Miekus K, Wanzeck J, Wojakowski W, et al. (2005) Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 23: 879-894. (Pubitemid 41170944)
6. Chirkov YY, Holmes AS, Willoughby SR, Stewart S, Horowitz JD (2002) Association of aortic stenosis with platelet hyperaggregability and impaired responsiveness to nitric oxide. Am J Cardiol 90: 551-554.
7. Theroux P, Fuster V (1998) Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction. Circulation 97: 1195-1206. (Pubitemid 28152893)
8. Chatterjee M, Huang Z, Zhang W, Jiang L, Hultenby K, et al. (2011) Distinct platelet packaging, release, and surface expression of proangiogenic and antiangiogenic factors on different platelet stimuli. Blood 117: 3907-3911.
9. Chatterjee M, Gawaz M (2013) Platelet-Derived CXCL12 (SDF-1alpha): Basic Mechanisms and Clinical Implications. J Thromb Haemost 11: 1954-67.
10. Wurster T, Stellos K, Haap M, Seizer P, Geisler T, et al. (2013) Platelet expression of stromal-cell-derived factor-1 (SDF-1): an indicator for ACS? Int J Cardiol 164: 111-115.
11. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, et al. (2007) ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 116: e148-304.
12. Waxman DA, Hecht S, Schappert J, Husk G (2006) A model for troponin I as a quantitative predictor of in-hospital mortality. J Am Coll Cardiol 48: 1755-1762. (Pubitemid 44648620)
13. Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, et al. (2002) ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation 106: 1883-1892.
14. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, et al. (2008) 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 118: e523-661.
15. Gawaz M, Neumann FJ, Schomig A (1999) Evaluation of platelet membrane glycoproteins in coronary artery disease: consequences for diagnosis and therapy. Circulation 99: E1-E11.
16. Gawaz M, Reininger A, Neumann FJ (1996) Platelet function and platelet-leukocyte adhesion in symptomatic coronary heart disease. Effects of intravenous magnesium. Thromb Res 83: 341-349. (Pubitemid 26284108)
17. Massberg S, Konrad I, Schurzinger K, Lorenz M, Schneider S, et al. (2006) Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med 203: 1221-1233. (Pubitemid 43736592)
18. Stellos K, Langer H, Daub K, Schoenberger T, Gauss A, et al. (2008) Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells. Circulation 117: 206-215.
19. Stellos K, Bigalke B, Langer H, Geisler T, Schad A, et al. (2009) Expression of stromal-cell-derived factor-1 on circulating platelets is increased in patients with acute coronary syndrome and correlates with the number of CD34+ progenitor cells. Eur Heart J 30: 584-593.
20. Stellos K, Rahmann A, Kilias A, Ruf M, Sopova K, et al. (2012) Expression of platelet-bound stromal cell-derived factor-1 in patients with non-valvular atrial fibrillation and ischemic heart disease. J Thromb Haemost 10: 49-55.
21. Geisler T, Fekecs L, Wurster T, Chiribiri A, Schuster A, et al. (2012) Association of platelet-SDF-1 with hemodynamic function and infarct size using cardiac MR in patients with AMI. Eur J Radiol 81 (4): e486-490.
22. Blackshear JL, Wysokinska EM, Safford RE, Thomas CS, Stark ME, et al. (2013) Indexes of von Willebrand factor as biomarkers of aortic stenosis severity (from the Biomarkers of Aortic Stenosis Severity [BASS] study). Am J Cardiol 111: 374-381
23. Goto S, Ikeda Y, Saldivar E, Ruggeri ZM (1998) Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. J Clin Invest 101: 479-486. (Pubitemid 28067346)
24. Natorska J, Bykowska K, Hlawaty M, Marek G, Sadowski J, et al. (2011) Increased thrombin generation and platelet activation are associated with deficiency in high molecular weight multimers of von Willebrand factor in patients with moderate-to-severe aortic stenosis. Heart 97: 2023-2028.
25. Peterson DM, Stathopoulos NA, Giorgio TD, Hellums JD, Moake JL (1987) Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa. Blood 69: 625-628. (Pubitemid 17022038)
26. O'Brien JR, Etherington MD, Brant J, Watkins J (1995) Decreased platelet function in aortic valve stenosis: high shear platelet activation then inactivation. Br Heart J 74: 641-644. (Pubitemid 26004635)
27. Biberthaler P, Mendler N, Ettner U, Meisner H (1998) Endothelial prostacyclin (PGI-2) production of human and porcine valve allografts related to ischemic history. Eur J Cardiothorac Surg 14: 503-507. (Pubitemid 28539312)
28. De Meyer E, Van Hove CE, Feng XJ, Rampart M, Herman AG (1995) Thrombin triggers the de novo expression of an inducible NO synthase in porcine aortic valve endothelial cells. Eur J Pharmacol 291: 67-72.
29. Chirkov YY, Mishra K, Chandy S, Holmes AS, Kanna R, et al. (2006) Loss of anti-aggregatory effects of aortic valve tissue in patients with aortic stenosis. J Heart Valve Dis 15: 28-33. (Pubitemid 43180522)
30. Dimitrow PP, Hlawaty M, Undas A, Sniezek-Maciejewska M, Sobień B, et al. (2009) Effect of aortic valve stenosis on haemostasis is independent from vascular atherosclerotic burden. Atherosclerosis 204: e103-108.
31. Luszczak J, Undas A, Gissel M, Olszowska M, Butenas S (2011) Activated factor XI and tissue factor in aortic stenosis: links with thrombin generation. Blood Coagul Fibrinolysis 22: 473-479.
32. Moake JL, Turner NA, Stathopoulos NA, Nolasco LH, Hellums JD (1986) Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest 78: 1456-1461. (Pubitemid 17219507)
33. Dimitrow PP, Undas A, Bober M, Tracz W, Dubiel JS (2008) Obstructive hypertrophic cardiomyopathy is associated with enhanced thrombin generation and platelet activation. Heart 94: e21.
34. Beckmann E, Grau JB, Sainger R, Poggio P, Ferrari G (2010) Insights into the use of biomarkers in calcific aortic valve disease. J Heart Valve Dis 19:441-452.